Inverse behavior of IL-23R and IL-17RA in chronic and aggressive periodontitis
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Periodontitis is associated with a dysbiosis of periodontopathic bacteria, which stimulate the interleukin (IL)-23/IL-17 axis that plays an essential role in the immunopathogenesis of this disease, leading to alveolar bone destruction through receptor activator of nuclear factor κB ligand (RANKL). IL-23 receptor mRNA (IL-23R) has been identified in periodontitis, and IL-17 receptor A mRNA (IL-17RA) and its protein have not yet been evaluated in patients with periodontitis. In this study was measure IL-23R and IL-17RA in gingival tissue (GT) from patients with generalized chronic periodontitis (GCP) and generalized aggressive periodontitis (GAP) and to explore correlations with clinical parameters. Methods: We included 16 healthy subjects (HS), 18 patients with GCP, and 14 with GAP. GT samples were collected during periodontal surgery. Both IL-23R and IL-17RA were detected by enzyme-linked immunosorbent assay. Results: The results were analyzed with Mann-Whitney U test and Spearman' rank correlation coefficients using SPSS version 25.0. We found lower IL-23R levels in patients with GCP and GAP than in HS. Contrarily, we observed higher IL-17RA levels in GCP and GAP patients than in HS. Moreover, we found negative correlations between IL-23R in GT and probing depth and clinical attachment loss (CAL). Likewise, a positive correlation of IL-17RA in GT with CAL was found. Conclusions: The results of these findings suggest that the reverse behavior between IL-23R and IL-17RA in periodontitis patients may also be involved with the activation of RANKL, which promotes alveolar bone loss.
Abstract
Purpose: Periodontitis is associated with a dysbiosis of periodontopathic bacteria, which stimulate the interleukin (IL)-23/IL-17 axis that plays an essential role in the immunopathogenesis of this disease, leading to alveolar bone destruction through receptor activator of nuclear factor κB ligand (RANKL). IL-23 receptor mRNA (IL-23R) has been identified in periodontitis, and IL-17 receptor A mRNA (IL-17RA) and its protein have not yet been evaluated in patients with periodontitis. In this study was measure IL-23R and IL-17RA in gingival tissue (GT) from patients with generalized chronic periodontitis (GCP) and generalized aggressive periodontitis (GAP) and to explore correlations with clinical parameters. Methods: We included 16 healthy subjects (HS), 18 patients with GCP, and 14 with GAP. GT samples were collected during periodontal surgery. Both IL-23R and IL-17RA were detected by enzyme-linked immunosorbent assay. Results: The results were analyzed with Mann-Whitney U test and Spearman' rank correlation coefficients using SPSS version 25.0. We found lower IL-23R levels in patients with GCP and GAP than in HS. Contrarily, we observed higher IL-17RA levels in GCP and GAP patients than in HS. Moreover, we found negative correlations between IL-23R in GT and probing depth and clinical attachment loss (CAL). Likewise, a positive correlation of IL-17RA in GT with CAL was found. Conclusions: The results of these findings suggest that the reverse behavior between IL-23R and IL-17RA in periodontitis patients may also be involved with the activation of RANKL, which promotes alveolar bone loss.
참고문헌 (40)
- Armitage GC, "Development of a classification system for periodontal diseases and conditions", Ann Periodontol, 4, pp.1~6 (1999)
- Weighardt H, "Identification of a TLR4-and TRIFdependent activation program of dendritic cells", Eur J Immunol, 34, pp.558~564 (2004)
- Parham C, "A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R", J Immunol, 168, pp.5699~5708 (2002)
- Floss DM, "Defining the functional binding sites of interleukin 12 receptor β1 and interleukin 23 receptor to Janus kinases", Mol Biol Cell, 27, pp.2301~2316 (2016)
- Song X, "IL-17 family cytokines mediated signaling in the pathogenesis of inflammatory diseases", Cell Signal, 25, pp.2335~2347 (2013)
- Kan SH, "Identification and characterization of multiple splice forms of the human interleukin-23 receptor alpha chain in mitogen-activated leukocytes", Genes Immun, 9, pp.631~639 (2008)
- Franke M, "Human and murine interleukin 23 receptors are novel substrates for a disintegrin and metalloproteases ADAM10 and ADAM17", J Biol Chem, 291, pp.10551~10561 (2016)
- Sohda M, "Identification of a soluble isoform of human IL-17RA generated by alternative splicing", Cytokine, 64, pp.642~645 (2013)
- Hienz SA, "Mechanisms of bone resorption in periodontitis", J Immunol Res, 2015, pp.615486~ (2015)
- Johnson RB, "Interleukin-11 and IL-17 and the pathogenesis of periodontal disease", J Periodontol, 75, pp.37~43 (2004)
- Takahashi K, "The potential role of interleukin-17 in the immunopathology of periodontal disease", J Clin Periodontol, 32, pp.369~374 (2005)
- Vernal R, "Levels of interleukin-17in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from patients with chronic periodontitis", J Clin Periodontol, 32, pp.383~389 (2005)
- Duarte PM, "Serum levels of cytokines in subjects with generalized chronic and aggressive periodontitis before and after non-surgical periodontal therapy : a pilot study", J Periodontol, 81, pp.1056~1063 (2010)
- Ozçaka O, "Interleukin-17 and interleukin-18 levels in saliva and plasma of patients with chronic periodontitis", J Periodontal Res, 46, pp.592~598 (2011)
- Himani GS, "Gingival crevicular fluid and interleukin-23 concentration in systemically healthy subjects : their relationship in periodontal health and disease", J Periodontal Res, 49, pp.237~245 (2014)
- Fu QY, "Correlation of chronic periodontitis in tropical area and IFN-γ, IL-10, IL-17 levels", Asian Pac J Trop Med, 6, pp.489~492 (2013)
- Ruíz-Gutiérrez AC, "Determinación de los niveles de IL-17 en el líquido crevicular gingival de pacientes con periodontitis crónica y agresiva", Rev Mex Periodontol, 5, pp.46~50 (2014)
- Mitani A, "Increased expression of interleukin (IL)-35 and IL-17, but not IL-27, in gingival tissues with chronic periodontitis", J Periodontol, 86, pp.301~309 (2015)
- Cifcibasi E, "Evaluation of local and systemic levels of interleukin-17, interleukin-23, and myeloperoxidase in response to periodontal therapy in patients with generalized aggressive periodontitis", Inflammation, 38, pp.1959~1968 (2015)
- Liukkonen J, "Salivary concentrations of interleukin (IL)-1β, IL-17A, and IL-23 vary in relation to periodontal status", J Periodontol, 87, pp.1484~1491 (2016)
- Peña-Echeverría PA, "Determinación de la concentración de IL-23 y el receptor soluble a IL-17(IL-17RA)en suero y plasma de pacientes con periodontitis crónica y agresiva : un estudio piloto", Rev Mex Periodontol, 8, pp.46~53 (2017)
- Chitrapriya MN, "Interleukin-17 and interleukin-18 levels in different stages of inflammatory periodontal disease", J Indian Soc Periodontol, 19, pp.14~17 (2015)
- Batool H, "Salivary levels of IL-6 and IL-17 could be an indicator of disease severity in patients with calculus associated chronic periodontitis", Biomed Res Int, 2018, pp.8531961~ (2018)
- Sadeghi R, "Interleukin-17 and interleukin-23 levels in gingival crevicular fluid of patients with chronic and aggressive periodontitis", Cent Eur J Immunol, 43, pp.76~80 (2018)
- Thorbert-Mros S, "Interleukin-17 producing T cells and interleukin-17mRNA expression in periodontitis and longstanding gingivitis lesions", J Periodontol, 90, pp.516~521 (2019)
- Rivadeneyra-Burgos C, "Determinación de los niveles del receptor soluble de IL-23 en suero y plasma de pacientes con periodontitis crónica y agresiva", Rev Mex Periodontol, 8, pp.5~10 (2017)
- Ohyama H, "The involvement of IL-23 and the Th17 pathway in periodontitis", J Dent Res, 88, pp.633~638 (2009)
- Hillyer P, "Investigating the role of the interleukin-23", -17A axis in rheumatoid arthritis, 2009, pp.48, 1581~1589
- van Baarsen LG, "Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to antiIL-17 therapy?", Arthritis Res Ther, 16, pp.426~ (2014)
- Sánchez-Hernández PE, "IL-12 and IL-18 levels in serum and gingival tissue in aggressive and chronic periodontitis", Oral Dis, 17, pp.522~529 (2011)
- Franco-Topete R, "IFN-γR2 is strongly expressed on endothelial cells of gingival tissues from patients with chronic periodontitis", J Appl Oral Sci, 26, pp.e20170291~ (2018)
- Sato K, "Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction", J Exp Med, 203, pp.2673~2682 (2006)
- Bostanci N, "Tumor necrosis factor-alpha-converting enzyme(TACE)levels in periodontal diseases", J Dent Res, 87, pp.273~277 (2008)
- Ghoreschi K, "Generation of pathogenic TH17 cells in the absence of TGF-β signalling", Nature, 467, pp.967~971 (2010)
- Liu S, "Inhibiting complex IL-17A and IL-17RA interactions with a linear peptide", Sci Rep, 6, pp.26071~ (2016)
- Lin D, "IL-17 regulates the expressions of RANKL and OPG in human periodontal ligament cells via TRAF6", TBK1-JNK, Immunology, pp.2014, 144[DOI]
- Caton JG, "A new classification scheme for periodontal and peri-implant diseases and conditions-Introduction and key changes from the 1999classification", J Clin Periodontol, 45(Suppl 20), pp.S1~8 (2018)
- Zaki AA, "The new classification of periodontal diseases", BDJ Team, 7, pp.32~33 (2020)
- Gaur S, "Alzheimer's disease and chronic periodontitis : Is there an association", Geriatr Gerontol Int, 15, pp.391~404 (2015)
- Ballerini P, "Conditioned medium from relapsing-remitting multiple sclerosis patients reduces the expression and release of inflammatory cytokines induced by LPS-gingivalis in THP-1 and MO3.13 cell lines", Cytokine, 96, pp.261~272 (2017)
